Mark Lythgoe, Academic Clinical Fellow in Medical Oncology and Pharmacist at Imperial College London, shared on X:
“Important Science and Innovation at Cancer Research UK, UCL led study improving outcomes in cervix cancer – 10yrs in the making and no expensive drugs.
Significants implications for standard of care globally in high and low income countries.”